Literature DB >> 19621022

Prognostic factors of sacral chordoma after surgical therapy: a study of 36 patients.

K W Chen1, H L Yang, J Lu, J Y Liu, X Q Chen.   

Abstract

STUDY
DESIGN: Retrospective study.
OBJECTIVES: To investigate prognostic factors of sacral chordomas and provide theoretical foundation for an improvement of continuous disease-free survival (CDFS).
METHODS: Thirty-six patients underwent initial operation for sacral chordoma between 1992 and 2007. Data regarding age, gender, tumor size, tumor location, and type of surgery, surgical margins, surrounding muscle invasion, radiation therapy, and recurrences were reviewed and analyzed statistically.
RESULTS: The average duration of follow-up was 74.4 months (range, 16-182 months). Sixteen patients developed local recurrences at the time of final follow-up. The average recurrence time was 30 months (range, 3-84 months). The 5-year and 10-year actuarial CDFS were 59.5 and 42%, respectively. CDFS was found statistically longer in patients whose tumor highest level at or below S3 compared with above S3 (P=0.047). Patients who had invasion into the surrounding muscle had a shorter CDFS than those without surrounding muscle invasion (P=0.014). Statistic analysis showed that the type of surgery was the most valuable indicator of CDFS (P=0.001). The local recurrence rate was statistically higher when an inadequate margin has been achieved (P=0.021). The Cox multivariate regression analysis showed that surrounding muscle invasion (P=0.024) was an independent adverse prognostic factor for CDFS, whereas incomplete excision (P=0.056) achieved borderline significance.
CONCLUSIONS: The higher level of tumor involvement, invasion into the surrounding muscle, incomplete excision, and inadequate surgical margins are poor prognostic factors. Resecting the tumor completely with wide surgical margins may provide a better prognosis for these patients.

Entities:  

Mesh:

Year:  2009        PMID: 19621022     DOI: 10.1038/sc.2009.95

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  29 in total

1.  Wide resection of sacral chordoma via a posterior approach.

Authors:  Apichat Asavamongkolkul; Saranatra Waikakul
Journal:  Int Orthop       Date:  2011-10-29       Impact factor: 3.075

2.  High expression of SPHK1 in sacral chordoma and association with patients' poor prognosis.

Authors:  Kai Zhang; Hao Chen; Guizhong Wu; Kangwu Chen; Huilin Yang
Journal:  Med Oncol       Date:  2014-09-27       Impact factor: 3.064

3.  Overexpression of Raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence.

Authors:  Kai Zhang; Hao Chen; Bin Zhang; Jiajia Sun; Jian Lu; Kangwu Chen; Huilin Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma.

Authors:  Kang-Wu Chen; Hui-Lin Yang; Jian Lu; Gen-Lin Wang; Yi-Ming Ji; Gui-Zhong Wu; Li-Fan Zhu; Jia-Yong Liu; Xiao-Qing Chen; Yong-Ping Gu
Journal:  J Neurooncol       Date:  2010-06-15       Impact factor: 4.130

5.  Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma.

Authors:  Matthias Uhl; Thomas Welzel; Alexandra Jensen; Malte Ellerbrock; Thomas Haberer; Oliver Jäkel; Klaus Herfarth; Jürgen Debus
Journal:  Strahlenther Onkol       Date:  2015-03-04       Impact factor: 3.621

Review 6.  Variables affecting functional improvement in chordoma patients admitted to an inpatient rehabilitation facility: A retrospective review.

Authors:  Sasha E Knowlton; Richard Goldstein; Kevin C O'Connor; Joseph Schwab; Francis Hornicek; Ross Zafonte
Journal:  J Spinal Cord Med       Date:  2017-05-02       Impact factor: 1.985

7.  "En bloc" resection of sacral chordomas by combined anterior and posterior surgical approach: a monocentric retrospective review about 29 cases.

Authors:  Arnaud Dubory; Gilles Missenard; Benoît Lambert; Charles Court
Journal:  Eur Spine J       Date:  2014-01-28       Impact factor: 3.134

8.  Recurrence and survival factors analysis of 171 cases of sacral chordoma in a single institute.

Authors:  Yongkun Yang; Xiaohui Niu; Yuan Li; Weifeng Liu; Hairong Xu
Journal:  Eur Spine J       Date:  2016-12-09       Impact factor: 3.134

Review 9.  Cryosurgery in the excision of a giant local recurrent sacral chordoma: a case report and literature review.

Authors:  Valerio Pipola; Marco Girolami; Riccardo Ghermandi; Giuseppe Tedesco; Gisberto Evangelisti; Alessandro Gasbarrini
Journal:  Eur Spine J       Date:  2018-01-25       Impact factor: 3.134

10.  Surgical management of chordoma: A systematic review.

Authors:  Luca Denaro; Alessandra Berton; Mauro Ciuffreda; Mattia Loppini; Vincenzo Candela; Maria Luisa Brandi; Umile Giuseppe Longo
Journal:  J Spinal Cord Med       Date:  2018-07-26       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.